Search research articles
Contact Us
Filters
Showing results (411-420 of 574) with videos related to
Page
of 58
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 30, 2005
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice
Syed Z Imam, Joseph Jankovic, Syed F Ali, et al.
Nature Reviews. Disease Primers
|
September 22, 2018
Dystonia
Bettina Balint, Niccolò E Mencacci, Enza Maria Valente, et al.
Journal of Neurology
|
March 24, 2018
Cervical dystonia and substance abuse
Abhimanyu Mahajan, Joseph Jankovic, Laura Marsh, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
August 15, 2014
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm
Hubert H Fernandez, Joseph Jankovic, John B Holds, et al.
Drug Design, Development and Therapy
|
April 22, 2015
Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
Wolfgang H Jost, Reiner Benecke, Dieter Hauschke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease
Yi Guo, Wei-Dong Le, Joseph Jankovic, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 23, 2008
Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease
Mario F Dulay, Adriana M Strutt, Harvey S Levin, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
April 24, 2013
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia
Hubert H Fernandez, Eric J Pappert, Cynthia L Comella, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
June 1, 2022
The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases?
Wenqin Du, Peter G Bain, Giovanni Defazio, et al.
Journal of Neurology
|
April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)
P David Charles, Charles H Adler, Mark Stacy, et al.
Page
of 58
Search research articles
Search
Showing results (411-420 of 574) with videos related to
Sort By:
Page
of 58
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 30, 2005
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice
Syed Z Imam, Joseph Jankovic, Syed F Ali, et al.
Nature Reviews. Disease Primers
|
September 22, 2018
Dystonia
Bettina Balint, Niccolò E Mencacci, Enza Maria Valente, et al.
Journal of Neurology
|
March 24, 2018
Cervical dystonia and substance abuse
Abhimanyu Mahajan, Joseph Jankovic, Laura Marsh, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
August 15, 2014
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm
Hubert H Fernandez, Joseph Jankovic, John B Holds, et al.
Drug Design, Development and Therapy
|
April 22, 2015
Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
Wolfgang H Jost, Reiner Benecke, Dieter Hauschke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease
Yi Guo, Wei-Dong Le, Joseph Jankovic, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 23, 2008
Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease
Mario F Dulay, Adriana M Strutt, Harvey S Levin, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
April 24, 2013
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia
Hubert H Fernandez, Eric J Pappert, Cynthia L Comella, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
June 1, 2022
The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases?
Wenqin Du, Peter G Bain, Giovanni Defazio, et al.
Journal of Neurology
|
April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)
P David Charles, Charles H Adler, Mark Stacy, et al.
Page
of 58